Literature DB >> 7664181

Interaction of human immunodeficiency virus type 1, human T-cell leukemia/lymphoma virus type I (HTLV-I), and HTLV-II with in vitro-generated dendritic cells.

D Zucker-Franklin1, M Fraig, G Grusky.   

Abstract

Although it is known that impairment of dendritic cells (DC) plays a role in the pathogenesis and immunosuppression of retrovirus-associated diseases, it is not clear whether, or to what extent, these antigen-presenting cells themselves become infected. The realization that the cells can be generated in vitro in larger numbers than can be isolated from circulating blood or bone marrow raised the possibility that they could be used for therapeutic purposes. Therefore, we investigated whether DC generated in vitro from CD34 precursors are susceptible to infection when cocultured with human immunodeficiency virus type 1- or human T-cell leukemia/lymphoma virus-infected cell lines. While there appears to be a remarkable affinity of the viruses for the plasma membranes of the DC, interiorization or budding was not observed in 30 experiments carried out under a variety of conditions.

Entities:  

Mesh:

Year:  1995        PMID: 7664181      PMCID: PMC170157          DOI: 10.1128/cdli.2.3.343-348.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  46 in total

1.  Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene.

Authors:  K Shimotohno; Y Takahashi; N Shimizu; T Gojobori; D W Golde; I S Chen; M Miwa; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

2.  Esterases in human leukocytes.

Authors:  C Y Li; K W Lam; L T Yam
Journal:  J Histochem Cytochem       Date:  1973-01       Impact factor: 2.479

3.  Initial event in mycosis fungoides of the skin is viral infection of epidermal Langerhans cells.

Authors:  R M MacKie
Journal:  Lancet       Date:  1981-08-08       Impact factor: 79.321

4.  Dendritic cell and macrophage staining by monoclonal antibodies in tissue sections and epidermal sheets.

Authors:  T J Flotte; T A Springer; G J Thorbecke
Journal:  Am J Pathol       Date:  1983-04       Impact factor: 4.307

5.  Transformation of monocytes into "fat" cells.

Authors:  D Zucker-Franklin; G Grusky; A Marcus
Journal:  Lab Invest       Date:  1978-05       Impact factor: 5.662

Review 6.  Progress in adult T cell leukemia research.

Authors:  M Hanaoka
Journal:  Acta Pathol Jpn       Date:  1982

7.  Isolation and transmission of human retrovirus (human t-cell leukemia virus).

Authors:  M Popovic; P S Sarin; M Robert-Gurroff; V S Kalyanaraman; D Mann; J Minowada; R C Gallo
Journal:  Science       Date:  1983-02-18       Impact factor: 47.728

8.  Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication.

Authors:  W C Van Voorhis; J Valinsky; E Hoffman; J Luban; L S Hair; R M Steinman
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

9.  Enhancement of antibody response by mouse dendritic cells pulsed with tobacco mosaic virus or with rabbit antiidiotypic antibodies raised against a private rabbit idiotype.

Authors:  M Francotte; J Urbain
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

10.  The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients.

Authors:  B A Pancake; D Zucker-Franklin; E E Coutavas
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more
  3 in total

1.  DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1-infected cells.

Authors:  Pierre-Emmanuel Ceccaldi; Frédéric Delebecque; Marie-Christine Prevost; Arnaud Moris; Jean-Pierre Abastado; Antoine Gessain; Olivier Schwartz; Simona Ozden
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

2.  Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission.

Authors:  Florian Hladik; Huanliang Liu; Emily Speelmon; Devon Livingston-Rosanoff; Sean Wilson; Polachai Sakchalathorn; Yon Hwangbo; Benjamin Greene; Tuofu Zhu; M Juliana McElrath
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  M Makino; S Shimokubo; S I Wakamatsu; S Izumo; M Baba
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.